abs393.txt	purpose		the	survival	benefit	from	detecting	additional	breast	cancers	bypreoperative	magnetic	resonance	imaging	(mri)	continues	to	be	controversial	methods		we	followed	a	cohort	of	4454	women	diagnosed	with	non-metastatic	breastcancer	(stage	i-iii)	from	2/2005-6/2010	in	five	registries	of	the	breast	cancersurveillance	consortium	(bcsc)		bcsc	clinical	and	registry	data	were	linked	tomedicare	claims	and	enrollment	data		we	estimated	the	cumulative	probability	ofbreast	cancer-specific	and	all-cause	mortality		we	tested	the	association	ofpreoperative	mri	with	all-cause	mortality	using	a	cox	proportional	hazards	model	results		917	(20	6%)	women	underwent	preoperative	mri		no	significant	differencein	the	cumulative	probability	of	breast	cancer-specific	mortality	was	found		weobserved	no	significant	difference	in	the	hazard	of	all-cause	mortality	duringthe	follow-up	period	after	adjusting	for	sociodemographic	and	clinical	factorsamong	women	with	mri	(hr	0	90		95%	ci	0	72-1	12)	compared	to	those	without	mri	conclusion		our	findings	of	no	breast	cancer-specific	or	all-cause	mortalitybenefit	supplement	prior	results	that	indicate	a	lack	of	improvement	in	surgicaloutcomes	associated	with	use	of	preoperative	mri		in	combination	with	otherreports		the	results	of	this	analysis	highlight	the	importance	of	exploring	thebenefit	of	preoperative	mri	in	patient-reported	outcomes	such	as	women's	decisionquality	and	confidence	levels	with	decisions	involving	treatment	choices	
